Intravitreal treatment in patients with exudative age-related macular degeneration and visual acuity ≤ 0.05

BACKGROUND: To investigate intravitreal treatment efficiencies in patients suffering from exudative ARMD with a BCVA ≤ 0.05. METHODS: Retrospective analysis: Analysis parameters were lesion type, BCVA at baseline and at follow-up, the intravitreal drug used, and its application frequency. Patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Koch, Raphael, Schmidt, Matthias, Gebauer, Sabine, Busse, Holger, Uhlig, Constantin E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618933/
https://www.ncbi.nlm.nih.gov/pubmed/26490832
http://dx.doi.org/10.1186/s12886-015-0123-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618933/
https://www.ncbi.nlm.nih.gov/pubmed/26490832
http://dx.doi.org/10.1186/s12886-015-0123-y

Ejemplares similares